Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy
PaperCitations, authors & open-access status
Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 103 citations, 2020 year and closed oa status.
103
Citations
2020
Year
closed
OA Status